Clinical peculiarities and laboratory indices in respiratory organs tuberculosis with dysfunctions of respiratory system Source: Eur Respir J 2006; 28: Suppl. 50, 14s Year: 2006
Clinical effectiveness of steroid treatment on lung function and immunologic markers in pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 86s Year: 2007
Human neutrophil peptides as biomarkers for monitoring respiratory functional impairment in sarcoidosis Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011
Changes parameters of non-specific immune defence during COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 511s Year: 2004
Alterations of surfactant phospholipids in lungs with chronic recurrent respiratory chlamydial infection Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011
Influence of N-acetylcystein in complex basic therapy on the dynamics of pulmonary function test indices in severe bronchial asthma patients Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
Analysis of the rheological properties of respiratory mucus and inflammatory alterations of the airways in patients with common variable immunodeficiency associated with bronchiectasis Source: Eur Respir J 2006; 28: Suppl. 50, 444s Year: 2006
Effect of carbohydrate metabolism disturbances on tolerence of physical load in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 638s Year: 2006
Nutritional modulation to correct metabolic alterations in chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020
Interrelation risk factors and spirography data with humoral immunity parameters during COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 586s Year: 2005
Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties Source: Eur Respir J 2002; 19: 797-804 Year: 2002
Alterations in metabolism and body composition in chronic respiratory diseases Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=11 Year: 2003
Protective metabolic reactions in pulmonary sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 265s Year: 2003
The role of calcium metabolism assessment in the clinical setting of interstitial lung diseases Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021
Evaluation of specific immune complexes in patients with pulmonary sarcoidosis. Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018
Comparing sputum rheology and spirometry as pathological markers in respiratory diseases Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
The role of nonspecific inflammation factors – SA-A and pentraxin-3 in patients with respiratory sarcoidosis in different age groups Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021
Evaluation of vitamin A supplement-therapy on immunologic profiles of pulmonary tuberculosis patient Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005
The abnormalities of phospholipid composition of bronchoalveolar lavage in sarcoidosis of respiratory organs Source: Eur Respir J 2001; 18: Suppl. 33, 68s Year: 2001